Your browser doesn't support javascript.
Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
Durstenfeld, Matthew S; Peluso, Michael J; Kaveti, Punita; Hill, Christopher; Li, Danny; Sander, Erica; Swaminathan, Shreya; Arechiga, Victor M; Lu, Scott; Goldberg, Sarah A; Hoh, Rebecca; Chenna, Ahmed; Yee, Brandon C; Winslow, John W; Petropoulos, Christos J; Kelly, J Daniel; Glidden, David V; Henrich, Timothy J; Martin, Jeffrey N; Lee, Yoo Jin; Aras, Mandar A; Long, Carlin S; Grandis, Donald J; Deeks, Steven G; Hsue, Priscilla Y.
  • Durstenfeld MS; Department of Medicine, University of California, San Francisco, CA, USA.
  • Peluso MJ; Division of Cardiology, Zuckerberg San Francisco General, San Francisco, CA, USA.
  • Kaveti P; Department of Medicine, University of California, San Francisco, CA, USA.
  • Hill C; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, USA.
  • Li D; Department of Medicine, University of California, San Francisco, CA, USA.
  • Sander E; Division of Cardiology, UCSF Health, San Francisco, CA, USA.
  • Swaminathan S; School of Medicine, University of California, San Francisco, USA.
  • Arechiga VM; Division of Cardiology, Zuckerberg San Francisco General, San Francisco, CA, USA.
  • Lu S; Division of Cardiology, UCSF Health, San Francisco, CA, USA.
  • Goldberg SA; Division of Cardiology, Zuckerberg San Francisco General, San Francisco, CA, USA.
  • Hoh R; Division of Cardiology, Zuckerberg San Francisco General, San Francisco, CA, USA.
  • Chenna A; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, USA.
  • Yee BC; School of Medicine, University of California, San Francisco, USA.
  • Winslow JW; Division of Cardiology, Zuckerberg San Francisco General, San Francisco, CA, USA.
  • Petropoulos CJ; LabCorp-Monogram Biosciences Inc, South San Francisco, CA  USA.
  • Kelly JD; LabCorp-Monogram Biosciences Inc, South San Francisco, CA  USA.
  • Glidden DV; LabCorp-Monogram Biosciences Inc, South San Francisco, CA  USA.
  • Henrich TJ; LabCorp-Monogram Biosciences Inc, South San Francisco, CA  USA.
  • Martin JN; Institute of Global Health Sciences, University of California, San Francisco, USA.
  • Lee YJ; F.I. Proctor Foundation, University of California, San Francisco, USA.
  • Aras MA; Division of Experimental Medicine, University of California, San Francisco, USA.
  • Long CS; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.
  • Grandis DJ; Department of Medicine, University of California, San Francisco, CA, USA.
  • Deeks SG; Division of Experimental Medicine, University of California, San Francisco, USA.
  • Hsue PY; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.
J Infect Dis ; 2023 May 11.
Article in English | MEDLINE | ID: covidwho-2314248
ABSTRACT

BACKGROUND:

Mechanisms underlying persistent cardiopulmonary symptoms following SARS-CoV-2 infection (post-acute sequelae of COVID-19 "PASC" or "Long COVID") remain unclear. This study sought to elucidate mechanisms of cardiopulmonary symptoms and reduced exercise capacity.

METHODS:

We conducted cardiopulmonary exercise testing (CPET), cardiac magnetic resonance imaging (CMR) and ambulatory rhythm monitoring among adults > 1 year after confirmed SARS-CoV-2 infection in a post-COVID cohort, compared those with or without symptoms, and correlated findings with previously measured biomarkers.

RESULTS:

Sixty participants (median age 53, 42% female, 87% non-hospitalized) were studied at median 17.6 months following SARS-CoV-2 infection. On CPET, 18/37 (49%) with symptoms had reduced exercise capacity (<85% predicted) compared to 3/19 (16%) without symptoms (p = 0.02). Adjusted peak VO2 was 5.2 ml/kg/min lower (95%CI 2.1-8.3; p = 0.001) or 16.9% lower percent predicted (95%CI 4.3-29.6; p = 0.02) among those with symptoms. Chronotropic incompetence was common. Inflammatory markers and antibody levels early in PASC were negatively correlated with peak VO2 more than 1 year later. Late-gadolinium enhancement on CMR and arrhythmias were absent.

CONCLUSIONS:

Cardiopulmonary symptoms >1 year following COVID-19 were associated with reduced exercise capacity, which was associated with elevated inflammatory markers early in PASC. Chronotropic incompetence may explain exercise intolerance among some with cardiopulmonary Long COVID.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Language: English Year: 2023 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Language: English Year: 2023 Document Type: Article Affiliation country: Infdis